Q1 2025 · 13F-HR
Pivotal bioVenture Partners Investment Advisor LLCholdings as filed
Filed 2025-05-14 · accession 0001012975-25-000233
$123.6M
Reported value
11
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| H5870P102 | OCS | OCULIS HOLDING AG | $43.8M | 35.4% | 2,300,774 | Common | SHARED |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $33.2M | 26.8% | 2,120,508 | Common | SHARED |
| 92243G108 | PCVX | VAXCYTE INC | $26.8M | 21.7% | 710,734 | Common | SHARED |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $5.8M | 4.71% | 736,645 | Common | SHARED |
| 45790W108 | — | INOZYME PHARMA INC | $4.1M | 3.31% | 4,494,851 | Common | SHARED |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $3.2M | 2.55% | 595,518 | Common | SHARED |
| 09077V100 | BIOA | BIOAGE LABS INC | $2.5M | 1.99% | 653,374 | Common | SHARED |
| 75120L100 | — | RALLYBIO CORP | $1.6M | 1.26% | 2,404,644 | Common | SHARED |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $997,859 | 0.81% | 560,595 | Common | SHARED |
| 449778109 | IOBTQ | IO BIOTECH INC | $941,975 | 0.76% | 864,197 | Common | SHARED |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $756,587 | 0.61% | 1,891,467 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.